ViriMASK
Protective Oculo-Respirator for Coronovirus Protection
Startup Pre-Funding Health Tech & Life Sciences Est. 2020
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
1
1-10 employees
Confidence
88/100
News
2
articles
About
ViriMASK has developed a face mask designed to provide maximum protection against micron-sized particles. Its filters retain inhaled and exhaled particles larger than 0.1 microns, such as bacteria and viruses, exhaled aerosols, and environmental aerosols. The filters retention capability coupled with the ViriMASKs lack of an exhalation valve prevents the spread of infection back into the environment. ViriMASKs full-face design straps around the head, covering the eyes with a see-through visor and the nose and mouth with a filtering mechanism. It is completely sealed to outside air penetration, preventing infection and contamination through the eyes. The mask also has low airflow resistance, which allows more comfortable breathing and minimal skin pressure for extended wear, and can be washed and disinfected. ViriMASK is a subsidiary of Oneg HaKarmel Ltd.
Classification
Sector
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Core Technology
Materials & Substances
Target Customer
Healthcare & Life SciencesHealthcarePatientsProviders
Business Model
B2CB2B
Tags
medical-equipmentmedical-technologiesrespiratorydoctorshospitals
News (2)
Jul 30, 2020 · www.timesofisrael.com
growth-positive
New Israeli-made mask claims to offer best protection yet against coronavirus
Customers
Mar 15, 2020 · www.israel21c.org
growth-positive
New ventilator mask protects entire face from coronavirus
CustomersExpand
Details
Product Stage
Released
Employees
1-10
Exact Count
1
District
North District
Founded
2020
Registrar
516178530
Crunchbase
virimask
Locations
Etgar Street 4, Tirat Carmel, Israel
Links
Admin
Last Update
Sep 20, 2023
Verified by
Yotam Maman
Missing
funding rounds, markets, external profiles, not claimed
Team (1)
Prof. Noam Gavriely
Founder
Founder
Internal
Created by
Maor Perlov (maorperlov@gmail.com)
Created
2020-08-03T00:00:00.000Z
Last editor
Matan Eblagon (matane@sncentral.org)